BioSpace News Archive

Policy

Isogenica Licenses CIS Display Technology to Aro Biotherapeutics for Centyrin-based Biopharmaceutical Development

Isogenica Ltd today announced that it has signed a new licensing agreement with Aro Biotherapeutics Company (Aro) of Philadelphia.

July 23, 2018
·
2 min read
Business

SanBio: Joint Research Agreement for SB623 Targeting Dementia

SanBio Company Limited announced it has concluded an agreement with Keio University School of Medicine on joint research for SB623 targeting dementia.

July 23, 2018
·
2 min read
OrthoSpin Ltd. Completes $3 Million Raise for Orthopedic Robotic External Fixation System

OrthoSpin Ltd. announced that it completed an investment round of $3 million for its smart, robotic external fixation system for orthopedic treatments.

July 23, 2018
·
2 min read
FDA

IDT’s Customer Senseonics Receives FDA Approval for its Implantable Glucose Sensor

Integrated Device Technology, Inc. announced that its customer Senseonics (Germantown, MD) received FDA approval for its Eversense® Continuous Glucose Monitoring (CGM) System for people with diabetes.

July 23, 2018
·
4 min read
Business

NanoViricides, Inc. Welcomes Dr. Irach Taraporewala as the New CEO

NanoViricides, Inc.is pleased to announce that the Company’s Board has appointed Dr. Irach Taraporewala as the new Chief Executive Officer (CEO).

July 23, 2018
·
4 min read
Business

BioTime to Announce Second Quarter 2018 Results on August 2, 2018

BioTime, Inc. today announced that it will release second quarter 2018 financial and operating results on Thursday, August 2, 2018, after the close of the U.S. financial markets.

July 23, 2018
·
3 min read
FDA

Amneal Announces FDA Approval and Launch of Generic Potassium Chloride Oral Solution

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced it has received U.S. Food and Drug Administration (FDA) approval on its Abbreviated New Drug Application for a generic version of Potassium Chloride oral solution.

July 23, 2018
·
7 min read
Business

Titan Spine Appoints Peter Wehrly to Board of Directors

Highly Respected Industry Veteran to Provide Expertise and Counsel.

July 23, 2018
·
4 min read
Biotech Beach

No Toxicity Seen in Mice as Regen BioPharma, Inc. Finishes Initial Optimization of its Lead NR2F6 Small Molecule Agonist

Regen BioPharma Inc.'s lead candidate drug, RG-NAE005, was tested for its maximum tolerated dose in mice and showed no signs of toxicity.

July 23, 2018
·
2 min read
Business

Clinical Innovations hires Richard Ji as vice president of operations

Clinical Innovations today announced the hiring of Richard Ji as its new vice president of operations.

July 23, 2018
·
3 min read